Shire Share Discussion Threads

[philanderer] 11/4/2018 09:20

#Down , down, deeper and down# ... 14 days remaining ....all very quiet ;-)

[philanderer] 10/4/2018 20:45

mbmiah, tend to agree with that.

Slightly down stateside from the London close.

[mbmiah] 10/4/2018 20:22

This won't go any higher, the chart says it all.

[philanderer] 10/4/2018 12:50

Strong £ , cable = 1.4185

[ny boy] 10/4/2018 10:37

Bear trap!

[philanderer] 10/4/2018 09:48

Exactly dt , about 100 people I reckon ;-)

[albo] 10/4/2018 09:47

I'm surprised that this is still below £37 given that we are only 2 weeks away from their deadline. Does this show that there is not much confidence in an offer of any real value being made??

[demo trader] 10/4/2018 09:28

Below 3000p or above 4200p?

Who knows !

[philanderer] 10/4/2018 09:06

Agree if Takeda bid that may well draw others out. If Takweda walk away however I don'tb think it'll happen. Bidders, if out there, can wait for the retrace.

Fifteen days and counting ;-)

[scobak] 10/4/2018 08:55

Takeda not likely to succeed but will act as catalyst for other pharmas. Takeda not likely to be all cash so there will be a considerable amount of paper issued.
Shire is undervalued at the moment and that is certainly the view of many posters to this board over the last 3 months......but then again it is not on its own, many UK companies are similarly badly undervalued take as an instance CARD reporting today.

SHP is capable of good organic growth and good cash generation to pay down its debts.
If the market can't see that at the moment then it is only a matter of time before it is. This is the nature of markets. This is what investing is all about and sometimes it needs a strong stomach and a clear mind.

Have faith.

[philanderer] 10/4/2018 00:32

What price if Takeda walk away ? ;-)

[ruethewhirl] 09/4/2018 22:38

Two weeks to go to deadline so new developments can’t be far away.

[scobak] 09/4/2018 20:04

Don't think much to a £45 take out price even if fully cash. Would feel that shp could make a better go of it organically.
Now £50 + is a better figure.
can't see any point in a dash for the door.

[philanderer] 09/4/2018 18:59

I'd take £45 ;-)


Shire bid could be bitter pill for Takeda, warns Lindsell

Star fund manager Michael Lindsell is worried about major holding Takeda Pharmaceutical's potential bid for Shire.

[mbmiah] 09/4/2018 17:37

I think if a deal in the region of £50+ was to be made, we would know by now. Looks to me like takeda want a good price e.g. £40-42 - not so good for shire holders.

[romeike] 09/4/2018 11:51

I'd expect a better offer price on multiple bidders, £45 is a pretty minimal acceptable level, people are too much focused on the recent negative slide rather than the longer term average price and fundamental value. At £45 you could easily argue that having more patience in the existing strategy could pay off better.

[broadwood] 09/4/2018 11:49

phil- yes, that's the way I read it too. Here's hopin'

[blueclyde] 09/4/2018 11:38

Bought a position this morning. I think it will be bought over. Highly cash generative, good pipeline of new drugs and cheap too. Debt not an issue considering how quickly they are paying it down. There are a number of cash rich big pharmaceutical companies that are going over a patient cliff that could come out bidding for this before it is snapped up imo. With the US tax reforms etc I would be surprise if another US company did not make a bid considering the manufacturing operations Shire now has in the US.

[philanderer] 09/4/2018 11:31

Hi broadwood.

Reading the articles since last wednesday it seems that Shire is willing to put itself up for sale - maybe hoping to flush out a few bidders - with a price of around 4500p , having used Takeda as a stalking horse.

[broadwood] 09/4/2018 11:26

Yes, I read the MoS article.

Seemed very positive. So, we await an offer, hopefully.

[philanderer] 08/4/2018 10:53

Two takes..


In 2014, U.S. drugmaker AbbVie proposed a $55 billion deal for Shire, but the agreement collapsed due to changes to tax rules by the U.S. Treasury Department. Shire then continued to look for buyers, said a source, and apparently contacted Takeda.


....Takeda has until 5 p.m. London time on April 25 to make a formal approach, but "the chances of an acquisition are not high," said Atsushi Seki, an analyst at UBS Securities.





======================================================================

Mail on Sunday

Analysts say Japanese firm stalking drugs giant Shire could launch 'credible offer' and win support from shareholders within weeks


Read more:

[adamb1978] 07/4/2018 14:09

Does feel like an offer will be made at some point - whether its at a price which SHP would recommend or not though, I'm somewhat sceptical. Could potentially get into a situation where Takeda go to SHP's investors and try to strong arm management into a deal, and we see a couple increased offers. Even if it were rebuffed though, it would provide some pep to the share price, even after it was rejected.

Also, can completely understand the comments that a lot of investors would take £45 per share. The share price has only be heading in one direction and the opportunity to take something like a 50% premium to where the price was prior to the speculation is something which financial investors would readily accept I feel.

[philanderer] 06/4/2018 21:04

SHP ... US close roughly unchanged from London close.